Publications

26 Jun 2000
Research & Ideas

Presentation Round-Up

get out of the way. But we also have to be prepared. Where the market fails to provide the service, we have to step in." Genes On The Web In a discussion moderated by HBS Professor Josh Lerner, participants in the panel on "Genes on the Web" emphasized the positive... View Details

Keywords: by Martha Lagace & Kenneth Liss; Technology; Communications; Telecommunications

December 2012
Teaching Note

Gene Patents (A) (TN)

By: Richard G. Hamermesh and Matthew Preble

This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details

Keywords: Biotech; Human Genome; Patents; Genetics; Biotechnology Industry; United States

17 Nov 2003
Research & Ideas

The Business of Babies

fertilization (IVF), surrogacy, and adoption demand payments of $10,000 and up. The largest demand in this market consists of infertile couples. Last year, some two million U.S. couples underwent fertility treatments. Additional demand includes same-sex couples, those... View Details

Keywords: by Julia Hanna; Health

29 May 2001
Research & Ideas

Genomics: Can We Start Making Money Now?

drugs, and will they be less expensive?' My answer is, 'I don't know, and probably not.' Lechleiter was one of several panelists to discuss, "Breaking the Genetic Code: The Business of Life Science in the 21st Century" at the... View Details

Keywords: by Sean Silverthorne

December 2000
Case

Paradigm Genetics: The Industrialization of Genomics

By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock

Keywords: Genetics; Biotechnology Industry

Find at Harvard

October – December 1998
Article

The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies

By: Arthur A. Daemmrich

Keywords: Genetics; Business Ventures

Find at Harvard

August 2007
Teaching Note

Teva Pharmaceutical Industries, Ltd (TN)

By: Tarun Khanna and Krishna G. Palepu

Teaching note to 707441. View Details

Keywords: Growth and Development Strategy; Cost; Competitive Strategy; Adoption; Emerging Markets; Change; Multinational Firms and Management; Genetics; Pharmaceutical Industry; India

24 Sep 2012
Research & Ideas

Why Do We Tax?

age, gender, height, and race. The most provocative, however, is for genetics. Once we know and understand genetic information better, we could, in principle, do a very good job of inferring individuals' innate abilities from the View Details

Keywords: by Martha Lagace; Legal Services

February 2008 (Revised August 2008)
Case

EXACT Sciences Corp.: Commercializing a Diagnostic Test

By: Regina E. Herzlinger

This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details

Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry

Find at Harvard

20 Dec 2004
Research & Ideas

How an Order Views Your Company

about customers and products or services. But, because of increasingly intense competition, one now had to look at individual orders. My research assistant (at the time) and I wrote a case with such detail that it proved to be very popular and useful. It is like having... View Details

Keywords: by Sarah Jane Johnston

15 Jan 2018
Research & Ideas

A Better Business Model for Fighting Cancer

question—it’s clear.” Simply put, inefficiencies in the development of precision medicine can best be addressed by a business-analysis approach. With the mapping of the human genome completed 15 years ago, the sci-fi concept of using a cancer patient’s View Details

Keywords: by Julia Hanna; Health; Pharmaceutical

September 2000
Case

Novartis Agricultural Discovery Institute (A)

Steve Briggs, a PhD biologist, is asked to propose a strategy to take global life-science giant Novartis into the rapidly expanding field of plant genomics. View Details

Keywords: Design; Plant-Based Agribusiness; Genetics; Infrastructure; Biotechnology Industry; Agriculture and Agribusiness Industry

June 2003 (Revised March 2008)
Case

Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

By: Regina E. Herzlinger and Marc Aquino

Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details

Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry

June 2011 (Revised October 2013)
Case

Gene Patents (A)

By: Richard Hamermesh, David Kiron and Phillip Andrews

In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details

Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States

25 Jul 2011
Research & Ideas

How Disruptive Innovation is Remaking the University

against the same criteria applied to his or her predecessor. The way things are done is determined not by individual preference but by institutional procedure written into the genetic code. There is evolution in the university, though its... View Details

Keywords: by Clayton M. Christensen & Henry J. Eyring; Education

24 Jan 2005
Research & Ideas

Entrepreneurial Hospital Pioneers New Model

But what's more interesting—and this is a function of operating in an environment such as India where heart disease is endemic—it's a genetic trait among Indians, and also there are so many people, so there are more heart ailments—is that... View Details

Keywords: by Martha Lagace; Health

November 1999
Case

E.I. du Pont de Nemours and Company (B)

DuPont must decide whether to launch a new non-GM (genetically modified) soybean that is tolerant to chemical sprays. In the face of rapid introductions of GM products by competitors, DuPont faces the challenge of ensuring the identity preservation of its new product... View Details

Keywords: Business Model; Customer Value and Value Chain; Genetics; Agriculture and Agribusiness Industry